Third-party payors manage 45.1% of $57.2 bil. retail prescription market in 1994 -- IMS data.
Executive Summary
THIRD-PARTY PAYORS COVER 45.1% OF $57.2 BIL. RETAIL Rx MARKET in 1994, or $25.8 bil., according to IMS America's Retail Method-of-Payment Report. Cash payments accounted for 41.6% ($23.8 bil.) with Medicaid covering the remaining 13.2% ($7.6 bil.). 1994 marked "the first year the dollar value of managed care prescriptions exceeded cash payments," IMS commented.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth